Oral dietary administration of Berberine resulted in p53-independent tumor growth arrest in an in vivo lung cancer model by inducing G1 cell-cycle arrest via inhibiting the proliferative kinase signaling axis comprising Akt, CREB, and MAPK [88]. This evidence concerns the gene AKT1 and lung cancer.